A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory MM
Clinical trial NCT04412889 · UNKNOWN
Trial details
- NCT number
- NCT04412889
- Sponsor
- Hebei Yanda Ludaopei Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2022-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.